Cargando…

CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance

BACKGROUND: Cervical cancer has ranked the top one in gynecological malignancies for incidence. Radioresistance is now becoming a leading reason of recurrence. METHODS: Our microRNA array data indicated that the miRNA-100 level decreased significantly during radioresistance. In this study, we up-reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Tingting, Yao, Yao, Chen, Zhiliao, Peng, Yongpai, Zhong, Guanglei, Huang, Chunxian, Li, Jing, Li, Ruixin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044740/
https://www.ncbi.nlm.nih.gov/pubmed/35477450
http://dx.doi.org/10.1186/s12935-022-02573-3
_version_ 1784695169205927936
author Yao, Tingting
Yao, Yao
Chen, Zhiliao
Peng, Yongpai
Zhong, Guanglei
Huang, Chunxian
Li, Jing
Li, Ruixin
author_facet Yao, Tingting
Yao, Yao
Chen, Zhiliao
Peng, Yongpai
Zhong, Guanglei
Huang, Chunxian
Li, Jing
Li, Ruixin
author_sort Yao, Tingting
collection PubMed
description BACKGROUND: Cervical cancer has ranked the top one in gynecological malignancies for incidence. Radioresistance is now becoming a leading reason of recurrence. METHODS: Our microRNA array data indicated that the miRNA-100 level decreased significantly during radioresistance. In this study, we up-regulated miR-100 in Hela and Siha cells by using miR-100 mimics and observed proliferation and invasion. RESULTS: It turned out that with overexpression of miR-100, the cells had less invasiveness as well as proliferation. It may target gene mTOR, and it deed reduced EMT. To examine the role of miR-100 in radioresistance, there was no significant result showed by BSP. While the circCASC15 has been identified with sponge function according to RNA pull down and ISH. CONCLUSION: The conclusions indicate miR-100 is a tumor suppressor gene and could be a therapeutic target in radio-resistant cervical cancers.
format Online
Article
Text
id pubmed-9044740
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90447402022-04-28 CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance Yao, Tingting Yao, Yao Chen, Zhiliao Peng, Yongpai Zhong, Guanglei Huang, Chunxian Li, Jing Li, Ruixin Cancer Cell Int Primary Research BACKGROUND: Cervical cancer has ranked the top one in gynecological malignancies for incidence. Radioresistance is now becoming a leading reason of recurrence. METHODS: Our microRNA array data indicated that the miRNA-100 level decreased significantly during radioresistance. In this study, we up-regulated miR-100 in Hela and Siha cells by using miR-100 mimics and observed proliferation and invasion. RESULTS: It turned out that with overexpression of miR-100, the cells had less invasiveness as well as proliferation. It may target gene mTOR, and it deed reduced EMT. To examine the role of miR-100 in radioresistance, there was no significant result showed by BSP. While the circCASC15 has been identified with sponge function according to RNA pull down and ISH. CONCLUSION: The conclusions indicate miR-100 is a tumor suppressor gene and could be a therapeutic target in radio-resistant cervical cancers. BioMed Central 2022-04-27 /pmc/articles/PMC9044740/ /pubmed/35477450 http://dx.doi.org/10.1186/s12935-022-02573-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Yao, Tingting
Yao, Yao
Chen, Zhiliao
Peng, Yongpai
Zhong, Guanglei
Huang, Chunxian
Li, Jing
Li, Ruixin
CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
title CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
title_full CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
title_fullStr CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
title_full_unstemmed CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
title_short CircCASC15-miR-100-mTOR may influence the cervical cancer radioresistance
title_sort circcasc15-mir-100-mtor may influence the cervical cancer radioresistance
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044740/
https://www.ncbi.nlm.nih.gov/pubmed/35477450
http://dx.doi.org/10.1186/s12935-022-02573-3
work_keys_str_mv AT yaotingting circcasc15mir100mtormayinfluencethecervicalcancerradioresistance
AT yaoyao circcasc15mir100mtormayinfluencethecervicalcancerradioresistance
AT chenzhiliao circcasc15mir100mtormayinfluencethecervicalcancerradioresistance
AT pengyongpai circcasc15mir100mtormayinfluencethecervicalcancerradioresistance
AT zhongguanglei circcasc15mir100mtormayinfluencethecervicalcancerradioresistance
AT huangchunxian circcasc15mir100mtormayinfluencethecervicalcancerradioresistance
AT lijing circcasc15mir100mtormayinfluencethecervicalcancerradioresistance
AT liruixin circcasc15mir100mtormayinfluencethecervicalcancerradioresistance